Ming-Chung Kan, PhD
Founder
VAXSIA Biomedical Inc.
Dr. Ming-Chung Kan is the founder of Vaxsia Biomedical Inc. He was graduated from Biomedical Science Program of University of Massachusetts Medical School, now Morningside Graduate School of Biomedical Science UMMS. He has been devoted in developing the self-adjuvanted protein nanoparticle platform, VADEX, since 2014 from scratch.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}